During the past decade, Beijing Boren Hospital conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 23 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Beijing Boren Hospital" #1 sponsor was "Beijing Boren Hospital" with 13 trials, followed by "Juventas Cell Therapy Ltd." with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Celgene" with 1 trials sponsored and "Chia Tai Tianqing Pharmaceutical Group Co., Ltd." with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Beijing Boren Hospital" #1 collaborator was "Nanjing Legend Biotech Co." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Beijing Boren Hospital" are "Multiple Myeloma" (4 trials), "Acute Lymphoblastic Leukemia, in Relapse" (3 trials), "Acute Myeloid Leukemia" (3 trials), "Acute Lymphoblastic Leukemia" (2 trials) and "Refractory Acute Lymphoblastic Leukemia" (2 trials). Many other conditions were trialed in "Beijing Boren Hospital" in a lesser frequency.

Most popular intervention types in "Beijing Boren Hospital" are "Biological" (14 trials) and "Drug" (9 trials). Other intervention types were less common.

The name of intervention was led by "Daratumumab" (2 trials), "Dexamethasone" (2 trials), "Elranatamab" (2 trials), "chimeric antigen receptor T cell" (2 trials) and "chimeric antigen receptor T cell treatment" (2 trials). Other intervention names were less common.

The vast majority of trials in "Beijing Boren Hospital" are 22 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Beijing Boren Hospital". 1 are not yet recruiting, 19 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Beijing Boren Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Beijing Boren Hospital, 12 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".